Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Drug Alcohol Depend. 2017 Apr 13;175:246–253. doi: 10.1016/j.drugalcdep.2017.02.012

Table 3.

Post hoc mixed model analysis of the effect of risk type on percent days abstinent (PDA; arcsine transformed) at 3, 6, and 12-month follow-up.

df F β
Time with High-Risk Friends
3-Month Assessment
PDA at 3-Month Follow-up 1, 240 58.39** −0.37
PDA at 6-Month Follow-up 1, 202 28.83** −0.40
PDA at 12-Month Follow-up 1, 189 30.15** −0.48
6-Month Assessment
PDA at 6-Month Follow-up 1, 213 18.31** −0.30
PDA at 12-Month Follow-up 1, 186 18.88** −0.36
12-Month Assessment
PDA at 12-Month Follow-up 1, 198 38.90** −0.46
Time with Low-Risk Friends
3-Month Assessment
PDA at 3-Month Follow-up 1, 240 5.53* 0.11
PDA at 6-Month Follow-up 1, 202 7.25** 0.19
PDA at 12-Month Follow-up 1, 189 5.07* 0.19
6-Month Assessment
PDA at 6-Month Follow-up 1, 213 37.43** 0.39
PDA at 12-Month Follow-up 1, 186 23.29** 0.37
12-Month Assessment
PDA at 12-Month Follow-up 1, 198 13.34** 0.29
Net-Risk of Time with Friends
3-Month Assessment
PDA at 3-Month Follow-up 1, 240 35.62** −0.004
PDA at 6-Month Follow-up 1, 202 19.14** −0.005
PDA at 12-Month Follow-up 1, 189 19.29** −0.006
6-Month Assessment
PDA at 6-Month Follow-up 1, 213 36.18** −0.006
PDA at 12-Month Follow-up 1, 186 41.73** −0.007
12-Month Assessment
PDA at 12-Month Follow-up 1, 198 50.15** −0.008

Notes: β represents unstandardized parameter estimates of arcsine transformed PDA data;

*

p < 0.05,

**

p < 0.01.